Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exscientia Ltd ADR (NQ: EXAI )

4.620 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 4.620
Bid (Size) 4.620 (10)
Ask (Size) 4.680 (13)
Prev. Close 4.620
Today's Range 4.620 - 4.620
52wk Range 3.860 - 9.100
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Exscientia plc (EXAI)
From Robbins LLP
Via GlobeNewswire
EXSCIENTIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Exscientia plc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire

Performance

YTD
-26.14%
-26.14%
1 Month
-14.92%
-14.92%
3 Month
-25.00%
-25.00%
6 Month
-9.41%
-9.41%
1 Year
-5.71%
-5.71%

More News

Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Exscientia
From Faruqi & Faruqi LLP
Via GlobeNewswire
Exscientia Earnings Preview
Via Benzinga
EXSCIENTIA PLC (NASDAQ: EXAI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Exscientia plc
From Bernstein Liebhard LLP
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Exscientia plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – EXAI
From The Rosen Law Firm, P.A.
Via Business Wire
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
Via Benzinga
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to Contact the Firm
From Schall Law
Via GlobeNewswire
The 10 Stocks In The Clinical-Stage BioTech Drug Stocks Index Are Down 4% YTD
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Six Of Seven AI Stock Categories Increased This Week
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why Ulta Beauty Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Exposures Glyphosate
EXAI Stock Earnings: Exscientia Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Exscientia Business and Financial Update for the Full Year 2023
From Exscientia plc
Via Business Wire
Earnings Scheduled For March 21, 2024
Via Benzinga
Exscientia to Report Full Year 2023 Financial Results on March 21, 2024
From Exscientia plc
Via Business Wire
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Via InvestorPlace
AI-Powered Drug Discovery Stocks Index Up 9% In February; Remains Down 8% YTD
Via Talk Markets
Exscientia to Present at Upcoming Investor Conferences in March
From Exscientia plc
Via Business Wire
Exscientia plc (EXAI) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
AI-Powered Drug Discovery Stocks Index Up 18% Last Week, Led By BioXcel Therapeutics
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
AI Drug Hunter Firm Exscientia Fires Its CEO Over 'Inappropriate' Relationships with Two Employees
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.